Imagene AI Company

Imagene provides AI-based molecular testing for cancer, detecting in real-time, a broad range of cancerous biomarkers from the biopsy image
Technology: Imaging
Industry: AI, Clinical Development
Headquarters: Tel Aviv, Tel Aviv, Israel
Founded Date: 2020-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 21500000
Last Funding Date: 2022-05-02
Last Funding Type: Series A

Visit Website
Register and Claim Ownership